Literature DB >> 20635825

Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy.

Roberto Leone1, Lara Magro, Ugo Moretti, Paola Cutroneo, Martina Moschini, Domenico Motola, Marco Tuccori, Anita Conforti.   

Abstract

BACKGROUND: Drug-drug interactions (DDIs) are an important cause of adverse drug reactions (ADRs). Many studies have recently considered this issue, but most of them focus only on potential interactions and are often related to the hospital setting. A spontaneous reporting database could be a valuable resource for detection of ADRs associated with DDIs; however, data in the literature are limited.
OBJECTIVE: To detect those patients treated with potentially interacting drugs and the cases where reported adverse reactions are a possible consequence of DDIs, using an Italian spontaneous reporting database.
METHODS: The data were obtained from a database containing all reports of suspected ADRs from five Italian regions (January 1990 to December 2007) that are the main contributors to the Italian spontaneous reporting system. All reports containing at least two drugs, reported as being suspected of causing the ADR or as concomitant medication, were selected and a list of drug pairs was drawn up. We performed a search to verify which drug pairs are considered a potential DDI, using the Internet version of the DRUGDEX(R) system. For each report containing a potential DDI, we verified whether the description of the adverse reaction corresponded to the interaction effect.
RESULTS: The database contained 45 315 reports, of which 17 700 (39.1%) had at least two reported drugs. We identified 5345 (30.2%) reports with potential DDIs, and in 1159 (21.7%) of these reports a related ADR was reported. The percentage of reports with potential DDIs increased in relation to the number of concomitantly administered drugs, ranging from 9.8% for two drugs to 88.3% for eight or more drugs. The percentages of serious or fatal reports of ADRs associated with a DDI were significantly higher than other reports analysed. The mean age, percentage of male patients and the mean number of drugs were also significantly higher in reports with DDIs than in other reports. In 235 of 1159 reports (20.3%), both interacting drugs were recognized as suspect by the reporter. This percentage varies in relation to the drugs involved, ranging from 2% to about 65%. The most frequently reported interaction was digoxin and diuretics, but no fatal ADRs were reported with this combination. The combination of anticoagulant and antiplatelet agents was responsible for the greatest number of serious reactions and deaths.
CONCLUSIONS: This study validates that spontaneous reporting, despite its limitations, can be an important resource for detecting ADRs associated with the concomitant use of interacting drugs. Moreover, our data confirm that DDIs could be a real problem in clinical practice, showing that more than one in five patients exposed to a potential DDI experienced a related ADR.

Entities:  

Mesh:

Year:  2010        PMID: 20635825     DOI: 10.2165/11534400-000000000-00000

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  46 in total

1.  Fluoroquinolones and risk of Achilles tendon disorders: case-control study.

Authors:  P D van der Linden; M C J M Sturkenboom; R M C Herings; H G M Leufkens; B H Ch Stricker
Journal:  BMJ       Date:  2002-06-01

2.  Analysis of overridden alerts in a drug-drug interaction detection system.

Authors:  Frédéric Mille; Céline Schwartz; Francoise Brion; Jean-Eudes Fontan; Olivier Bourdon; Patrice Degoulet; Marie-Christine Jaulent
Journal:  Int J Qual Health Care       Date:  2008-09-10       Impact factor: 2.038

3.  Drug-drug interactions related to hospital admissions in older adults: a prospective study of 1000 patients.

Authors:  J Doucet; P Chassagne; C Trivalle; I Landrin; M D Pauty; N Kadri; J F Ménard; E Bercoff
Journal:  J Am Geriatr Soc       Date:  1996-08       Impact factor: 5.562

4.  Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three italian regions.

Authors:  Roberto Leone; Mauro Venegoni; Domenico Motola; Ugo Moretti; Valentina Piazzetta; Alfredo Cocci; Domenico Resi; Federico Mozzo; Giampaolo Velo; Liliana Burzilleri; Nicola Montanaro; Anita Conforti
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 5.  Stroke in women.

Authors:  Monica Saini; Ashfaq Shuaib
Journal:  Recent Pat Cardiovasc Drug Discov       Date:  2008-11

Review 6.  Epidemiology of drug-drug interactions as a cause of hospital admissions.

Authors:  C A Jankel; L K Fitterman
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

Review 7.  Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies.

Authors:  Chuenjid Kongkaew; Peter R Noyce; Darren M Ashcroft
Journal:  Ann Pharmacother       Date:  2008-07-01       Impact factor: 3.154

8.  Drug interactions with cholinesterase inhibitors: an analysis of the French pharmacovigilance database and a comparison of two national drug formularies (Vidal, British National Formulary).

Authors:  Neda Tavassoli; Agnes Sommet; Maryse Lapeyre-Mestre; Haleh Bagheri; Jean-Louis Montrastruc
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 9.  Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs.

Authors:  Lise Aagaard; Ebba Holme Hansen
Journal:  BMC Clin Pharmacol       Date:  2009-03-03

10.  Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes.

Authors:  Emma C Davies; Christopher F Green; Stephen Taylor; Paula R Williamson; David R Mottram; Munir Pirmohamed
Journal:  PLoS One       Date:  2009-02-11       Impact factor: 3.240

View more
  31 in total

1.  Prevalence of potential drug-drug interactions in bone marrow transplant patients.

Authors:  Rosimeire Barbosa Fonseca Guastaldi; Adriano Max Moreira Reis; Albert Figueras; Silvia Regina Secoli
Journal:  Int J Clin Pharm       Date:  2011-10-13

2.  Adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study.

Authors:  Paulo Roque Obreli-Neto; Alessandro Nobili; André de Oliveira Baldoni; Camilo Molino Guidoni; Divaldo Pereira de Lyra Júnior; Diogo Pilger; Juliano Duzanski; Mauro Tettamanti; Joice Mara Cruciol-Souza; Walderez Penteado Gaeti; Roberto Kenji Nakamura Cuman
Journal:  Eur J Clin Pharmacol       Date:  2012-05-30       Impact factor: 2.953

3.  Pharmacodynamic and pharmacokinetic drug interactions reported to VigiBase, the WHO global individual case safety report database.

Authors:  Johanna Strandell; Stina Wahlin
Journal:  Eur J Clin Pharmacol       Date:  2011-01-21       Impact factor: 2.953

Review 4.  Drug-drug interaction software in clinical practice: a systematic review.

Authors:  Tina Roblek; Tomaz Vaupotic; Ales Mrhar; Mitja Lainscak
Journal:  Eur J Clin Pharmacol       Date:  2014-12-23       Impact factor: 2.953

5.  Data-driven prediction of drug effects and interactions.

Authors:  Nicholas P Tatonetti; Patrick P Ye; Roxana Daneshjou; Russ B Altman
Journal:  Sci Transl Med       Date:  2012-03-14       Impact factor: 17.956

6.  Key elements in adverse drug interaction safety signals: an assessment of individual case safety reports.

Authors:  Johanna Strandell; G Niklas Norén; Staffan Hägg
Journal:  Drug Saf       Date:  2013-01       Impact factor: 5.606

7.  Characterisation of non-warfarin-associated bleeding events reported to the Norwegian spontaneous reporting system.

Authors:  Sigrid Narum; Vigdis Solhaug; Kirsten Myhr; Odd Brørs; Marianne Kristiansen Kringen
Journal:  Eur J Clin Pharmacol       Date:  2013-02-20       Impact factor: 2.953

8.  Drug-related deaths in hospital inpatients: A retrospective cohort study.

Authors:  Eva Montané; Ana Lucía Arellano; Yolanda Sanz; Josep Roca; Magí Farré
Journal:  Br J Clin Pharmacol       Date:  2018-01-11       Impact factor: 4.335

9.  Impact of specific Beers Criteria medications on associations between drug exposure and unplanned hospitalisation in elderly patients taking high-risk drugs: a case-time-control study in Western Australia.

Authors:  Sylvie D Price; C D'Arcy J Holman; Frank M Sanfilippo; Jon D Emery
Journal:  Drugs Aging       Date:  2014-04       Impact factor: 3.923

10.  The importance of drug-drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France.

Authors:  Francois Montastruc; Agnès Sommet; Emmanuelle Bondon-Guitton; Geneviève Durrieu; Eric Bui; Haleh Bagheri; Maryse Lapeyre-Mestre; Laurent Schmitt; Jean-Louis Montastruc
Journal:  Eur J Clin Pharmacol       Date:  2011-11-25       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.